imipramine has been researched along with Movement Disorders in 13 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (92.31) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HERVE, Y | 1 |
CARRIE, J | 1 |
LE MAILLOUX, E | 1 |
VIDAL, G | 1 |
VIDAL, B | 1 |
WHITTIER, J | 1 |
HAYDU, G | 1 |
CRAWFORD, J | 1 |
FOSTER, AR | 1 |
LANCASTER, NP | 1 |
KORANYI, L | 1 |
ENDROECZI, E | 1 |
LISSAK, K | 1 |
HAEFNER, H | 1 |
KUTSCHER, I | 1 |
Dilsaver, SC | 1 |
Greden, JF | 1 |
Corral, C | 1 |
Lissavetzky, J | 1 |
Manzanares, I | 1 |
Darias, V | 1 |
Expósito-Orta, MA | 1 |
Martïn Conde, JA | 1 |
Sánchez-Mateo, CC | 1 |
Shelkunov, EL | 1 |
Markham, CH | 1 |
Birkmayer, W | 1 |
Radzuweit, H | 1 |
Knorr, W | 1 |
Sedivec, V | 1 |
Valenová, Z | 1 |
Paceltová, L | 1 |
2 reviews available for imipramine and Movement Disorders
Article | Year |
---|---|
[COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
Topics: Agranulocytosis; Autonomic Nervous System Diseases; Chemical and Drug Induced Liver Injury; Chlorpro | 1964 |
Antidepressant withdrawal phenomena.
Topics: Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; | 1984 |
11 other studies available for imipramine and Movement Disorders
Article | Year |
---|---|
[The excito-motor complications caused by imipramine (Tofranil)].
Topics: Imipramine; Movement; Movement Disorders; Psychopharmacology | 1960 |
[An unusual complication of imipramine].
Topics: Coma; Humans; Imipramine; Movement; Movement Disorders; Psychopharmacology; Sweating; Urination Diso | 1961 |
Effect of imipramine (Tofranil) on depression and hyperkinesia in Huntington's disease.
Topics: Chorea; Depression; Depressive Disorder; Humans; Huntington Disease; Hyperkinesis; Imipramine; Movem | 1961 |
Disturbance of motor function during treatment with imipramine.
Topics: Humans; Imipramine; Movement; Movement Disorders; Tranquilizing Agents | 1959 |
HYPERMOTILITY EVOKED BY LESIONS OF THE SEPTUM AND ANTERIOR HYPOTHALAMUS.
Topics: Aminopyrine; Amygdala; Atropine; Body Temperature; Caudate Nucleus; Cerebral Ventricles; Chlorpromaz | 1963 |
Synthesis and preliminary pharmacological evaluation of thiophene analogues of viloxazine as potential antidepressant drugs.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Apomorphine; Blepharoptosis; Dose-Response Rela | 1999 |
[Effect of imipramine-like antidepressants on head shaking induced by 5-hydroxytryptophan in mice].
Topics: Animals; Antidepressive Agents; Brain; Imipramine; Mice; Movement Disorders; Serotonin | 1978 |
The "on-off" side effect of L-DOPA.
Topics: Age Factors; Amitriptyline; Aromatic Amino Acid Decarboxylase Inhibitors; Athetosis; Carbidopa; Cate | 1974 |
[Conservative therapy in the Parkinson syndrome].
Topics: Amantadine; Antidepressive Agents; Dihydroxyphenylalanine; Humans; Imipramine; Injections, Intraveno | 1971 |
[Influencing of biological and immunologic pregnancy reactions by psychotropic drugs].
Topics: Adolescent; Adult; Aged; Butyrophenones; Chlorpromazine; Dementia; Depressive Disorder, Major; Dysau | 1969 |
Persistent extrapyramidal oral dyskinesias following treatment with thymoleptics.
Topics: Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder, Major; Facial Muscles; Female; Huma | 1970 |